UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Pennsylvania 23-1210010 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) (Mark One) 530 Herman O. West Drive, Exton, PA 19341-0645 ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Address of principal executive offices) (Zip Code) For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d ...

Third-Quarter 2022 WST Q3 2022 Earnings 1 Third Quarter Overall Net Sales $686.9M | 2.8% Diluted Earnings Per Share: $1.59 Adjusted Diluted Earnings Per Share: $2.03 "While our base, non-COVID-19 demand continues to grow, we have had multiple constraints that impacted our financial results. Delays in expansion projects as well as customer delivery timing and mix-shift related productivity impacts resulted in lower-than-expected overall high-value product (HVP) net sales. We expect to resolve these issues in ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2022 Earnings Conference Call October 27, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President-Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Paul Knight – KeyBanc Larry Solow – CJS Securities Derik DeBruin – Bank of America Dave Windley – Jefferies Jacob Johnson – Stephens Operator Good day and thank you for standing by. Welcome to the Q3 2022 West Pharmaceutical Ser ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or ot ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Quintin Lai – Vice President, Investor Relations Eric Green – Chief Executive Officer Bernard Birkett – Chief Financial Officer Conference Call Participants Derik de Bruin – Bank of America Paul Knight – KeyBanc Larry Solow – CJS Securities Justin Lin – William Blair Jacob Johnson – Stephens Dave Windley – Jefferies Operator Good day, and thank you for standing by. Welcome to the Q2 2 ...

Second-Quarter 2022 WST Q2 2022 Earnings 1 Second Quarter Overall Net Sales $771.3M | 6.6% Diluted Earnings Per Share: $2.48 Adjusted Diluted Earnings Per Share: $2.47 "We delivered excellent second-quarter results with Proprietary Products organic net sales growth in the high-teens, led by demand for our high-value products (HVPs)." "Our base business continues to be strong, reflecting our team's successful execution of strategic initiatives and dedication to improving patient lives. In the quarter, COVID- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) Pennsylvania 23-1210010 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 530 Herman O. West Drive, Exton, PA 19341-0645 (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended Marc ...

West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2022 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Quintin Lai - VP, IR Eric Green - President and CEO Bernard Birkett - CFO Conference Call Participants Larry Solow - CJS Securities Justin Lin - William Blair Paul Knight - KeyBanc Jacob Johnson - Stephens Derik De Bruin - Bank of America Dave Windley - Jefferies Operator Good day and thank you for standing by. Welcome to the Q1 2022 West Pharmaceutical Services Earnings Conference C ...

First-Quarter 2022 First Quarter Overall Net Sales $720.0M | 7.4% Diluted Earnings Per Share: $2.29 | 15.1% Adjusted Diluted Earnings Per Share: $2.30| 12.2% WST Q1 2022 Earnings 1 "We delivered a solid first-quarter 2022 and remain on track to increase capacity throughout the year to satisfy the growing demand for our highvalue products (HVP)." "Our team members across the globe continue to demonstrate their passion to improve patient lives as they remain focused on executing our strategic initiatives desp ...

☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-8036 WEST PHARMACEUTICAL SERVICES, INC. (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Common Stock, par value $.25 per share W ...